Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-07Clinical Trial Update: Collaborative Cardiac Care Project [NA]
The Collaborative Cardiac Care Project trial, sponsored by the U.S. Department of Veterans Affairs, has completed. The document lists indica…
-
CLINICAL_TRIALS other · 2015-04-07Clinical Trial Update: Evaluation of a Local Preconditioning Effect in Patients Undergoing Cardiac Surgery [NA]
A terminated clinical trial from the Medical University of Vienna evaluated a local preconditioning effect in patients undergoing cardiac su…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY
This clinical trial update reports completion of a study validating an intracycle CT motion correction algorithm to improve diagnostic accur…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Stress Testing Compared to Coronary Computed Tomographic Angiography in Patients With Suspected Coronary Artery Disease [Phase 3]
Phase 3 clinical trial comparing stress testing with coronary CT angiography in patients with suspected coronary artery disease has complete…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Plaque REgression With Cholesterol Absorption Inhibitor or Synthesis Inhibitor Evaluated by IntraVascular UltraSound [Phase 4]
A Phase 4 clinical trial evaluated plaque regression using either a cholesterol absorption inhibitor or a cholesterol synthesis inhibitor, a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-30Clinical Trial Update: Twelve vs 24 Months of Dual Antiplatelet Therapy in Patients With Coronary Revascularization for In-stent Restenosis [Phase 4]
A Phase 4 clinical trial update compares 12 versus 24 months of dual antiplatelet therapy in patients who have undergone coronary revascular…
-
FDA approval · 2015-03-26FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Brilinta (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery [Phase 4]
Phase 4 trial update examining ticagrelor in combination with aspirin to prevent cardiovascular events after coronary artery bypass grafting…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Safety Study to Assess the Feasibility of Use in Humans of the TAXUS Petal Bifurcation Coronary Stent System [Phase 1]
Phase 1 safety feasibility study in humans evaluating the TAXUS Petal Bifurcation Coronary Stent System. The trial is sponsored by Boston Sc…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Novara Registry of Platinum-Chromium Platform Stents
This document provides an update on the Novara Registry of Platinum-Chromium platform coronary stents, with the trial status listed as UNKNO…
-
CLINICAL_TRIALS research · 2015-03-26Clinical Trial Update: Single Long vs Two Short Overlapping Bioabsorbable Polymer DES [NA]
Clinical trial update comparing a single long bioabsorbable polymer drug-eluting stent to two short overlapping stents for coronary artery d…
-
CLINICAL_TRIALS other · 2015-03-26Clinical Trial Update: Biomime Stent in All-comers PCI Patients Registry
An administrative update related to the Biomime Stent registry study in all-comers patients undergoing percutaneous coronary intervention.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions
Clinical trial update evaluating the safety and efficacy of the CRE8 sirolimus-eluting stent for de novo coronary artery lesions.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions [Phase 3]
Phase 3 clinical trial update on the CRE8 stent for de novo coronary artery lesions, assessing safety and efficacy.
-
CLINICAL_TRIALS withdrawal · 2015-03-25Clinical Trial Update: Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating myocardial blood flow and blood flow reserve by transoesophageal echocardiography in patients with cor…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Diagnostic Performances of Computed TomographIc Coronary Angiography and Intravascular Ultrasound
This completed study evaluates the diagnostic performance of computed tomography coronary angiography and intravascular ultrasound for diagn…
-
CLINICAL_TRIALS research · 2015-03-24Clinical Trial Update: Optimal Physiologic Intravascular Ultrasound Imaging Criteria After Drug Eluting Stent Implantation
This update describes research into optimal physiologic intravascular ultrasound imaging criteria after drug-eluting stent implantation to i…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent [NA]
A clinical trial evaluating the PRO-Kinetic Energy cobalt-chromium bare-metal coronary stent for coronary artery disease was terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: VH-IVUS Plaque Composition Analysis By Fractional Flow Reserve
Clinical trial update reporting on VH-IVUS plaque composition analysis by fractional flow reserve in coronary artery disease.
-
FDA approval · 2015-03-23FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC to update the labeling.
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Rubidium-82 Position Emission Computed Tomography (PET) Versus Gated, Rest / Stress Technetium 99-m SPECT
This clinical trial update reports a completed comparison study of Rubidium-82 PET imaging versus Technetium-99m SPECT imaging in patients w…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Aerobic Exercise and Oxygen Uptake Efficiency Slope in Coronary Artery Disease [Phase 2]
Phase 2 clinical trial evaluating aerobic exercise and oxygen uptake efficiency slope in Coronary Artery Disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: ION US Post-Approval Study
US post-approval study results for the ION coronary device were completed and results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel [Phase 2]
Clinical trial update on a Phase 2 paclitaxel-eluting PTCA-balloon catheter to treat coronary stenosis; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-19Clinical Trial Update: Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA
An ancillary study under the CARDIA trial exploring autoimmunity and its relationship with coronary artery disease has completed.